Sequential Burkholderia cenocepacia Isolates from Siblings with Cystic Fibrosis Show Increased Lung Cell Attachment
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F17%3A10373194" target="_blank" >RIV/00216208:11130/17:10373194 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00064203:_____/17:10373194
Výsledek na webu
<a href="https://doi.org/10.1164/rccm.201607-1360LE" target="_blank" >https://doi.org/10.1164/rccm.201607-1360LE</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1164/rccm.201607-1360LE" target="_blank" >10.1164/rccm.201607-1360LE</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Sequential Burkholderia cenocepacia Isolates from Siblings with Cystic Fibrosis Show Increased Lung Cell Attachment
Popis výsledku v původním jazyce
Burkholderia cepacia complex (Bcc) is a group of 20 genetically distinct bacterial species (1) that has a severe impact on the quality of life of people with cystic fibrosis (CF) and is associated with a more rapid decline of lung function than Pseudomonas aeruginosa (2). B. cenocepacia is the most virulent species within the Bcc and is most frequently associated with septicemia, although other Bcc species have also been linked to bloodstream infections (BSI) (2, 3). Many pathogens alter their phenotype during chronic infection in response to changing selection pressures, coinfecting species, and antimicrobial therapies (4, 5). Studies on bacterial adaptation in the CF context have predominantly focused on P. aeruginosa; however, the adaptive strategies of B. cenocepacia isolates have also been examined (4, 6, 7). Antimicrobial resistance, loss of motility, tolerance of iron limitation, and increased virulence to host cells over time of chronic infection were reported. In contrast, P. aeruginosa and another member of the Bcc, B. multivorans, showed reduced virulence over time of infection (5, 8). We have examined two series of sequential isolates from two adult male siblings with CF (referred to as P1 and P2). Both patients became infected with Bcc during their teens and were chronically infected when transitioning to adult care.
Název v anglickém jazyce
Sequential Burkholderia cenocepacia Isolates from Siblings with Cystic Fibrosis Show Increased Lung Cell Attachment
Popis výsledku anglicky
Burkholderia cepacia complex (Bcc) is a group of 20 genetically distinct bacterial species (1) that has a severe impact on the quality of life of people with cystic fibrosis (CF) and is associated with a more rapid decline of lung function than Pseudomonas aeruginosa (2). B. cenocepacia is the most virulent species within the Bcc and is most frequently associated with septicemia, although other Bcc species have also been linked to bloodstream infections (BSI) (2, 3). Many pathogens alter their phenotype during chronic infection in response to changing selection pressures, coinfecting species, and antimicrobial therapies (4, 5). Studies on bacterial adaptation in the CF context have predominantly focused on P. aeruginosa; however, the adaptive strategies of B. cenocepacia isolates have also been examined (4, 6, 7). Antimicrobial resistance, loss of motility, tolerance of iron limitation, and increased virulence to host cells over time of chronic infection were reported. In contrast, P. aeruginosa and another member of the Bcc, B. multivorans, showed reduced virulence over time of infection (5, 8). We have examined two series of sequential isolates from two adult male siblings with CF (referred to as P1 and P2). Both patients became infected with Bcc during their teens and were chronically infected when transitioning to adult care.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10606 - Microbiology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
American Journal of Respiratory and Critical Care Medicine
ISSN
1073-449X
e-ISSN
—
Svazek periodika
195
Číslo periodika v rámci svazku
6
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
4
Strana od-do
832-835
Kód UT WoS článku
000396640500020
EID výsledku v databázi Scopus
2-s2.0-85015957945